{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:09:13Z","timestamp":1772575753340,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ijrobp.2009.02.037","type":"journal-article","created":{"date-parts":[[2009,5,23]],"date-time":"2009-05-23T08:56:36Z","timestamp":1243068996000},"page":"824-830","source":"Crossref","is-referenced-by-count":148,"title":["Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer"],"prefix":"10.1016","volume":"76","author":[{"given":"Christopher H.","family":"Crane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry W.","family":"Feig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Skibber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora A.","family":"Janjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipen M.","family":"Maru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee M.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Rodriguez-Bigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2009.02.037_bib1","first-page":"1465","article-title":"Gastrointestinal Tumor Study Group","volume":"312","author":"Prolongation of the disease-free interval in surgically treated rectal carcinoma","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199103143241101","article-title":"Effective surgical adjuvant therapy for high-risk rectal carcinoma","volume":"324","author":"Krook","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib4","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in t3-4 rectal cancers: Results of FFCD 9203","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1245\/ASO.2006.09.908","article-title":"The promises and potential pitfalls of organ preservation for locally advanced rectal cancer","volume":"3","author":"Crane","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib7","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2007.25.18_suppl.4041","article-title":"Phase I\/II study of neoadjuvant bevacizumab with radiation therapy and 5-fluorouracil in patients with rectal cancer: Initial results. ASCO Annual Meeting Proceedings, Part I","volume":"25","author":"Willett","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib8","doi-asserted-by":"crossref","first-page":"8136","DOI":"10.1200\/JCO.2005.02.5635","article-title":"Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: Continued experience of a phase I trial in rectal cancer patients","volume":"23","author":"Willett","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1200\/JCO.2005.03.6780","article-title":"Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer","volume":"24","author":"Crane","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib10","series-title":"AJCC cancer staging manual","author":"American Joint Committee on Cancer","year":"2002"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib11","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ijrobp.2004.04.062","article-title":"Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients","volume":"60","author":"Bonnen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib12","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1200\/JCO.2004.08.173","article-title":"Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis","volume":"22","author":"Gunderson","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canrad.2007.12.006","article-title":"Combining radiation with oxaliplatin: A review of experimental results","volume":"12","author":"Hermann","year":"2008","journal-title":"Cancer\/Radiother"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0360-3016(99)00062-0","article-title":"Radiation enhancement by 9-aminocamptothecin: The effect of fractionation and timing of administration","volume":"44","author":"Kirichenko","year":"1999","journal-title":"Int JRadiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11894-007-0052-x","article-title":"Adjuvant therapy for colon cancer","volume":"9","author":"Aranha","year":"2007","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib16","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1016\/j.ijrobp.2005.07.283","article-title":"Neoadjuvant chemoradiation with capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: A matched pair analysis","volume":"63","author":"Das","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijrobp.2008.05.054","article-title":"Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for t3\/t4 rectal adenocarcinoma: ECOG E1297","volume":"72","author":"Rosenthal","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3816\/CCC.2007.n.030","article-title":"Combined-modality therapy for rectal cancer: Future prospects","volume":"6","author":"Czito","year":"2007","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0360-3016(02)03863-4","article-title":"Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer","volume":"55","author":"Mehta","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1200\/JCO.2005.03.6095","article-title":"Randomized Phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012","volume":"24","author":"Mohiuddin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib22","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/bjs.1800801040","article-title":"Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma","volume":"80","author":"P\u00e5hlman","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02234816","article-title":"Abdominoperineal resection for rectal cancer at a specialty center","volume":"44","author":"Nissan","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2009.02.037_bib24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijrobp.2007.02.001","article-title":"Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results","volume":"68","author":"Czito","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609003290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609003290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T17:34:33Z","timestamp":1589823273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301609003290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0360301609003290"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2009.02.037","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}